ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,266 | -28.8% | 710 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $4,587 | +71.3% | 710 | +100.0% | 0.00% | +200.0% |
| Q1 2023 | $2,677 | -25.6% | 355 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $3,596 | -70.0% | 355 | -71.7% | 0.00% | -71.4% |
| Q3 2022 | $12,000 | -99.9% | 1,255 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $13,366,000 | +15624.7% | 1,255 | -71.9% | 0.01% | -85.2% |
| Q4 2021 | $85,000 | +37.1% | 4,463 | +44.0% | 0.05% | +54.3% |
| Q3 2021 | $62,000 | +55.0% | 3,100 | +72.2% | 0.04% | +9.4% |
| Q2 2021 | $40,000 | – | 1,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |